![]() | ||||||
lung cancer | ||||||
网页 | ||||||
Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer ... PLoS One. 2018 Jan 31;13(1):e0189766. doi: 10.1371/journal.pone.0189766. eCollection 2018. Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor. Park S(1), Ha S(2), Lee SH(1)(3), ...
| ||||||
Curative resection for lung cancer in octogenarians is justified Abstract. BACKGROUND: Due to an increased life expectancy in a healthy aging population and a progressive incidence of lung cancer, curative pulmonary resections can be performed even in octogenarians. The present study aims to investigate whether surgery is justified in patients reaching the age ...
| ||||||
Treatment of limited disease small cell lung cancer Small cell lung cancer (SCLC) presents multiple interdisciplinary challenges with several paradigm shifts in its treatment in recent years. SCLC treatment requires multidisciplinary management and timely treatment. The aim of this review is to focus on the team management aspects in the treatment of ...
| ||||||
Long non-coding RNA ZEB2-AS1 promotes proliferation and inhibits apoptosis in human lung ... Lung cancer is among the leading causes of cancer‑associated mortality worldwide, with a low 5‑year survival rate of 16.1%. However, the underlying molecular mechanisms behind lung cancer tumorigenesis remain largely unknown. Long non‑coding RNAs (lncRNAs) have been demonstrated to serve ...
| ||||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
![]() |
发送反馈 |
No comments:
Post a Comment